The clinical trial titled “A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)” (NCT06768658), sponsored by Takeda, was terminated due to business reasons before enrolling any participants. Specific details regarding these business reasons were not disclosed.
1 Discontinued Research Program
43 employees laid off. All pre-clinical programs paused.
67 employees laid off in New Jersey.
Laying off up to 17 employees.
Company closed and laid off all staff.
27% reduction in workforce.
75% reduction in workforce.
Laying off an undisclosed number of employees.
The APATIT-G study was a pilot clinical trial conducted by the University of Rochester to evaluate the safety and effectiveness of avatrombopag in treating thrombocytopenia caused by temozolomide in glioma patients. However, the study was terminated by the sponsor before it could be completed.
1 Discontinued Research Program
Laying off about 40 non-U.S. employees.
